Human Bone Marrow Mesenchymal Stem Cells Rescue Endothelial Cells Experiencing Chemotherapy Stress by Mitochondrial Transfer Via Tunneling Nanotubes
Overview
Affiliations
Tunneling nanotubes (TNTs) are newly discovered tubular structures between two distant cells that facilitate the intercellular exchange of signals and components. Recent reports show that mesenchymal stem cells (MSCs) can rescue injured target cells and promote recovery from a variety of stresses via TNT-mediated mitochondrial transfer. In this study, we explored how TNTs form between bone marrow MSCs and endothelial cells (ECs) by using a human umbilical cord vein endothelial cell (HUVEC) model. TNT formation between MSCs and HUVECs could be induced by treating HUVECs with cytarabine (Ara-C), and human bone marrow mesenchymal stem cells (hBMMSCs) could transfer mitochondria to injured HUVECs through TNTs. Mitochondrial transfer from hBMMSCs to HUVECs via TNTs rescued the injured HUVECs by reducing apoptosis, promoting proliferation and restoring the transmembrane migration ability as well as the capillary angiogenic capacity of HUVECs. This study provides novel insights into the cell-cell communication between MSCs and ECs and supports the results of prior studies indicating that ECs promote hematopoietic regeneration. An improved understanding of MSC-EC cross-talk will promote the development of MSC-directed strategies for improving EC function and hematopoietic system regeneration following myelosuppressive and myeloablative injuries.
Vaamonde-Garcia C, Hermida-Gomez T, Paniagua-Barro S, Burguera E, Blanco F, Fernandez-Moreno M Cells. 2025; 14(3).
PMID: 39936943 PMC: 11817340. DOI: 10.3390/cells14030151.
Barutta F, Corbetta B, Bellini S, Gambino R, Bruno S, Kimura S Clin Sci (Lond). 2024; 138(23):1537-1559.
PMID: 39535903 PMC: 11609313. DOI: 10.1042/CS20242064.
From dysfunction to healing: advances in mitochondrial therapy for Osteoarthritis.
Zhang M, Wu J, Cai K, Liu Y, Lu B, Zhang J J Transl Med. 2024; 22(1):1013.
PMID: 39529128 PMC: 11552139. DOI: 10.1186/s12967-024-05799-z.
Mitochondrion-based organellar therapies for central nervous system diseases.
Zhao M, Wang J, Zhu S, Wang M, Chen C, Wang L Cell Commun Signal. 2024; 22(1):487.
PMID: 39390521 PMC: 11468137. DOI: 10.1186/s12964-024-01843-z.
Yao W, Zhou J, Tang C, Zhang J, Chen Z, Li Y ACS Nano. 2024; 18(39):26733-26750.
PMID: 39238258 PMC: 11447894. DOI: 10.1021/acsnano.4c06921.